The Mérieux Développement-Gimv consortium is an ideal tandem that brings to the table health sector specialists as well as substantial financial resources, which is perfectly suited to support the Group’s growth challenges.
Jérôme Empereur - Stiplastics Healthcaring's Chairman-CEO
SGH Healthcaring
Stiplastics Healthcaring (founded in 1985) designs, develops and manufactures standard and smart plastic solutions for the pharmaceutical industries and the health sector. Based in Saint-Marcellin (Isère - France), the company currently employs over 90 people on a 10,000 m2 industrial site opened last October. The Group expects to achieve turnover of EUR 21 million in the current 2017/2018 financial year, 98% of which will be generated by the health sector. Exports account for 55% of Stiplastics’ turnover, thanks to its development of devices for the dispensing of solid-form medications (especially in the USA).
Share
2018
EUR 48 m
208
France
When ambition meets ambition
The company has a strong development potential in the connected health sector, with new products in the pipeline and a modern workshop for the production of electronic products in a controlled environment. In order to meet the new needs of patients and healthcare actors faced with changing pathologies and uses, and more specifically the increasing prominence of connected care, the Group has set up its IoC [Internet Of Care]® unit, which is dedicated to designing, developing and producing e-health medical devices. In addition, several partnership agreements were finalised in 2017 in what is an extremely promising sector, which will benefit patients and practitioners alike. Mérieux Développement and Gimv (joint investment by Gimv and the Gimv Health & Care fund) have joined forces to acquire Stiplastics Healthcaring.
Together, we build a leading company
The Mérieux Développement-Gimv consortium will contribute its complementary expertise in the health sector and support the growth of this French company.
